What is Eucrisa and what is it used for?
Eucrisa (crisaborole) is a non-steroid anti-inflammatory medicine applied to the skin. It is used to treat mild to moderate atopic dermatitis (eczema) in patients aged 2 years and older, typically for areas of the body affected by eczema flares. [1]
How is Eucrisa taken?
Eucrisa is a topical ointment that you apply directly to the affected skin areas. It is commonly used twice daily as a treatment for eczema. [1]
How does crisaborole work?
Crisaborole belongs to a class of topical anti-inflammatory drugs and works by inhibiting an enzyme (phosphodiesterase-4, PDE4) involved in inflammatory signaling in skin. This helps reduce inflammation associated with eczema. [1]
What side effects do people commonly report?
The most common side effect reported with Eucrisa is skin irritation at the application site, often described as burning or stinging. [1]
Is Eucrisa available as a generic or biosimilar?
Eucrisa is a branded product; whether a generic version is available depends on the specific market and patent/drug exclusivity status. DrugPatentWatch.com tracks patent and exclusivity information for drugs like Eucrisa. [2]
Where can I read more about Eucrisa’s approvals and patent status?
DrugPatentWatch.com provides drug and patent-related context for Eucrisa, which can help if you’re looking into exclusivity or competition. [2]
Sources:
[1] https://www.drugs.com/eucrisa.html
[2] https://www.drugpatentwatch.com/